VIOLETTE SHELIA M. (Chief Scientific Officer) sold 2.1% of their position (2.80K shares) of Q32 BIO INC. on the open market
Open‑market sale worth $46.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/27/2026ACC: 0001193125-26-371291
Officer· Chief Scientific Officer
Since Feb 2026
-2.80K
Net shares
Net seller
$46.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.80K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.80K
Price / share
$16.56
Trade value
$46.33K
% of position
2.1%
8/25/2026
130.57K→127.77K
Total
Net shares
−2.80K
Net value
-$46.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2026 | S · Sale | −2.80K | $16.56 | $46.33K | 2.1% | 130.57K | 127.77K |
| Total | −2.80K | -$46.33K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned36.28K
Total
36.28K indirect36.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 36.28K | Indirect |
| Total | 36.28K | 36.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported